"It's not the tragedies that define our lives, but the choices we make to face them"

Arrow up
Arrow down
Ott 12, 2021

Delta Med accelerates its growth path thanks to White Bridge Investments II acquisition

White Bridge Investments II acquires Delta Med from Augens Capital, aiming at supporting the company’s growth and consolidation in the medical devices market


Milan (Italy). October 11th, 2021 – White Bridge Investments II S.p.A. (“White Bridge”) completed the acquisition of Delta Med, a leading company in the vascular access market, from Augens Capital and the firm’s management.


Delta Med, which operates in its Viadana, Brescello and Sondrio facilities, developed in recent years under Augens Capital’s control, through the consolidation of certain companies active in the central and peripheral vascular access market, including safety and closed systems, urodynamics and dialysis products and procedural kits for operating room.

The transaction is aimed at supporting the company’s future growth trajectory and creating an investment platform to further pursue an aggregation and consolidation process in the medical devices industry, both in Italy and Europe.
White Bridge believes that Delta Med and its subsidiaries, Tipromed and BEL, represent a leading company in the Italian landscape, and that, thanks to the strong specialization and know-how developed over time, it will be able to further strengthen its positioning within the medical devices market.

Augens Capital, which acquired the company in 2015, and the managers of Delta Med will reinvest in the firm alongside White Bridge.

The transaction has been financed by Banco BPM and Credit Agricole, who have been supported by Riccardo Rossi, Giulia Lamon and Matteo Venuti of Studio Chiomenti.

White Bridge has been assisted by Matteo Manfredi, Pietro Braicovich, and Marco Mezzadri of Houlihan Lokey, Leonardo Graffi, Andrea Novarese, Tiziana Germinario, and Nicolò Miglio of White & Case, partners Marco Bastasin and Mario De Blasi of Deloitte, and partner Andrea Veneri of EY Parthenon.

Delta Med and Augens Capital have been assisted by Piper Sandler as financial advisor, EY for the vendor accounting and tax due diligence, PwC for the vendor commercial due diligence, and Fabio Labruna and Giulia Fioramonti of LMS on all legal matters.

In this page you can find all the latest news about Delta Med medical devices, product catalog updates and official press releases of the company. Would you like to receive all the latest information about us? Subscribe to our newsletter by filling out the appropriate form.

Stay update!